Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADME of [14C]CM082 in Healthy Chinese Male Subjects
NCT04434326Phase 1Completed
- Sponsor
- AnewPharma Company, Ltd.
- Start
- Jul 2021
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of vorolanib in solid tumor, sponsored by AnewPharma Company, Ltd. Primary endpoints: Radioactivity concentration of each plasma sample, Radioactivity concentration of each urine samples and 3 more. Started Jul 2021; status: completed.
02
Drugs
vorolanib
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT04434326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04434326.